Streetbeat News

Stock Prices

LXFR

Luxfer Holdings (NYSE:LXFR) reported Q2 earnings of $0.27 per share, missing the analyst consensus estimate of $0.30 by 10%. This is a 25% decrease from the same period last year. The company also reported quarterly sales of $110.40 million, missing the analyst consensus estimate of $111.00 million by 0.54%. This is a 0.82% increase from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

July 25, 2023 | 8:36 pm

MMSI

Merit Medical Systems has projected its FY23 net sales to be between $1.23 billion and $1.244 billion, which is in line with the estimated $1.23 billion. The company also expects its adjusted EPS to be between $2.81 and $2.91, slightly varying from the estimated $2.90.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:35 pm

CR

Crane Co. has revised its FY23 total sales growth forecast to approximately 6%, up from the previous estimate of 5%. The company also expects core sales growth to be between 5% and 7%, an increase from the prior range of 4% to 6%.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:35 pm

MTDR

Matador Resources has increased the midpoint of its 2023 total oil production guidance from 26.85 million barrels to 27.15 million barrels.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:35 pm

USO

The American Petroleum Institute (API) reported a build of 1.319 million barrels in the weekly crude stock, against an estimated draw of 1.969 million barrels.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:34 pm

CR

Crane Co. has increased its FY23 adjusted EPS guidance from $3.60-$3.90 to $3.80-$4.10, with a consensus of $3.86.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:34 pm

UMBF

UMB Financial reported Q2 earnings of $1.93 per share, beating the analyst consensus estimate of $1.92 by 0.52 percent. However, this is a 31.8 percent decrease from the same period last year. The company's quarterly sales of $363.69 million missed the analyst consensus estimate of $375.71 million by 3.20 percent, marking a 9.33 percent decrease from the previous year.

Portfolio Pulse from vinayak@benzinga.com

July 25, 2023 | 8:33 pm

EQT

EQT Corporation has projected its total sales volume for Q3 2023 to be between 475Bcfe and 525Bcfe. The company also expects its FY23 sales volume to range from 1,900Bcfe to 2,000Bcfe.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:33 pm

TMO

A significant bearish stance has been taken on Thermo Fisher Scientific (NYSE:TMO) by a large investor or institution, as indicated by unusual options activity. The sentiment among these big-money traders is split between 33% bullish and 66% bearish. Whales have been targeting a price range from $530.0 to $640.0 for TMO over the last 3 months. Credit Suisse has upgraded TMO to Outperform with a price target of $620.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 8:31 pm

DHR

A significant bearish stance has been taken on Danaher (NYSE:DHR) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 36% bullish and 63% bearish. Whales have been targeting a price range from $195.0 to $300.0 for Danaher over the last 3 months. Raymond James has downgraded its action to Outperform with a price target of $270.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 8:31 pm